SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: (Original Filing)
[NEWS RELEASE Skystar Bio-Pharmaceutical Announces Record Organic Revenues of $18.5 Million For Third Quarter Fiscal Year 2010 - Company reiterates fiscal 2010 guidance of $45.5 Million to $47.5 Million - XI’AN, CHINA – November 16, 2010 -- - Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ("Skystar" or the "Company"), Third Quarter 2010 Highlights · Revenue increases 45% YoY to record $18.5 million ·]
